Delayed CT to evaluate renal masses incidentally discovered at contrast-enhanced CT: demonstration of vascularity with deenhancement
Macari M; Bosniak MA
PURPOSE: To determine whether delayed computed tomography (CT) can help confirm vascularity in a neoplasm and differentiate it from a high-density cyst when a well-demarcated homogeneous high-attenuating (> 30-HU) renal mass is incidentally discovered during contrast material-enhanced CT. MATERIALS AND METHODS: In 25 patients, 26 well-demarcated, homogeneous high-attenuating renal masses (mean diameter, 2.5 cm; range, 1-4 cm) detected at initial postcontrast CT were further evaluated with delayed CT (mean, 38 minutes; range, 15-240 minutes) performed with identical parameters. On both the initial postcontrast and delayed CT scans, region-of-interest measurements were obtained in renal masses and in the gallbladder or low-density renal cysts as controls. Correlation with surgical or additional imaging findings was used to determine proof of diagnosis. RESULTS: Nine of the masses demonstrated no change in attenuation between initial postcontrast and delayed CT, indicating that they represented avascular lesions consistent with high-density cysts. These cases were confirmed with prior or follow-up imaging studies that demonstrated stability. Seventeen masses (nine surgically proved neoplasms and eight neoplasms that demonstrated interval growth at follow-up or previous CT) demonstrated decreased attenuation at delayed CT compared with initial postcontrast CT, which indicates vascularity. CONCLUSION: Delayed CT of incidentally discovered well-demarcated homogeneous high-attenuating (> 30-HU) renal masses detected at postcontrast CT enables differentiation of high-density cysts from renal neoplasms by demonstrating deenhancement as a proof of vascularity and, hence, neoplasm
PMID: 10580938
ISSN: 0033-8419
CID: 6251
MR imaging in the evaluation of small (< or =3.0 cm) renal masses
Rofsky NM; Bosniak MA
The use of MR imaging in evaluating renal tumors has expanded beyond the established utility for patients with renal insufficiency and allergy to iodinated contrast. MR imaging is increasingly relied on for the evaluation of small renal lesions. The use of gadolinium chelate contrast agents, high performance MR systems, and optimized techniques is essential. This article details our experience using MR to evaluate small renal tumors and reviews the clinical issues pertinent to the management of these lesions
PMID: 8995125
ISSN: 1064-9689
CID: 12397